Radiation-Induced Paneth Cell Dysfunction

辐射引起的潘氏细胞功能障碍

基本信息

项目摘要

Public exposure to radiation due to large-scale radiation incidents is a rising global concern. Acute radiation syndrome (ARS) is associated with high morbidity and mortality, but no FDA-approved therapeutics for gastrointestinal (GI) ARS. Therefore, delineating the mechanisms underlying radiation injury to develop targeted medical countermeasures (MCM) is a high priority. The GI mucosal immune system is susceptible to ionizing radiation, and dysfunctional mucosal immunity is a major contributing factor in the pathogenesis of ARS. The gap in this field is that the precise mechanisms by which radiation impairs the mucosal immune system and immune dysfunction-mediated dysbiosis of gut microbiota and multi-organ injury (MOI) are poorly defined. The long-term goal of our research is to identify the radiation- sensitive immune-specific pathways and test and develop novel immune dysfunction-targeted MCM for radiation exposure. Endotoxemia and systemic inflammation are common conditions associated with morbidity and mortality in ARS. Clinical and experimental evidence indicates that intestinal dysbiosis (depleted beneficial species, increased pathobionts, and decreased diversity) is a prerequisite for developing endotoxemia, systemic inflammation, and MOI. a-Defensins are antibacterial peptides secreted from Paneth cells, the highly specialized intestinal epithelial cells, to maintain microbiota homeostasis. Human Paneth cells produce two a-defensins - defensin 5 (HD5) and 6 (HD6). Our preliminary data show that ionizing radiation in mouse intestine 1) depletes Paneth cell a-defensins, 2) reduces mucosal Tcf4 mRNA, 3) alters microbiota composition, 4) disrupts epithelial barrier, and 5) consequent mucosal inflammatory response, endotoxemia, and systemic inflammation. Importantly, HD5 administered in the diet at 24 h post-irradiation mitigates altered gut microbiota, gut barrier dysfunction, and endotoxemia. These findings form the scientific premise (FIG 1) and support the central hypothesis that “HD5 mitigates GI-ARS by reversing dysbiosis of gut microbiota and epithelial barrier dysfunction, leading to mitigation of endotoxemia and systemic inflammation.” We will test this hypothesis by determining that 1) Ionizing radiation downregulates Wnt signaling in intestinal Paneth cells, 2) TCF4 down-regulation mediates radiation-induced a-defensin depletion and consequent dysbiosis, 3) a-Defensin supplementation reverses radiation-induced dysbiosis of gut microbiota, 4) Radiation-induced dysbiosis drives gut barrier dysfunction, endotoxemia, and systemic inflammation, 5) the lowest and most effective dose of HD5 in mitigating GI- ARS, 6) the ideal time window for post-exposure (+24-96 h) effectiveness of HD5 to reverse GI-ARS, and 7) the HD5 treatment paradigm to increase the survival rates from lethal dose radiation. .
大规模辐射事件造成的公众辐射暴露是一个日益令人关切的全球问题。急性 放射综合征(ARS)与高发病率和死亡率相关,但FDA尚未批准 胃肠道(GI)ARS的治疗剂。因此,描绘辐射的机制 制定有针对性的医疗对策(MCM)是一个高度优先事项。胃肠道黏膜免疫 系统易受电离辐射影响,粘膜免疫功能障碍是主要原因 ARS发病机制中的一个因素。这一领域的差距在于, 损害粘膜免疫系统和免疫功能障碍介导的肠道微生物群的生态失调, 多器官损伤(MOI)定义不明确。我们研究的长期目标是确定辐射- 敏感的免疫特异性途径,并测试和开发新的免疫功能障碍靶向MCM, 辐射暴露内毒素血症和全身性炎症是与内毒素血症相关的常见病症。 发病率和死亡率。临床和实验证据表明,肠道生态失调 (耗尽有益物种,增加致病菌,减少多样性)是一个先决条件, 发展为内毒素血症、全身炎症和MOI。α-防御素是一种分泌型抗菌肽 来自潘氏细胞,高度特化的肠上皮细胞,以维持微生物群的稳态。 人潘氏细胞产生两种α-防御素-防御素5(HD 5)和6(HD 6)。我们的初步数据显示 电离辐射在小鼠肠道中1)耗尽潘氏细胞α-防御素,2)降低粘膜Tcf 4 mRNA,3)改变微生物群组成,4)破坏上皮屏障,和5)随后的粘膜 炎症反应、内毒素血症和全身炎症。重要的是,HD 5在 辐照后24小时的饮食减轻了改变的肠道微生物群、肠道屏障功能障碍和内毒素血症。 这些发现形成了科学前提(图1),并支持中心假设,即“HD 5减轻了 通过逆转肠道微生物群的生态失调和上皮屏障功能障碍, 内毒素血症和全身炎症。”我们将通过确定1)电离 辐射下调肠道潘氏细胞中的Wnt信号,2)TCF 4下调介导 辐射诱导的α-防御素耗竭和随后的生态失调,3)α-防御素补充逆转 辐射诱导的肠道微生物群的生态失调,4)辐射诱导的生态失调驱动肠道屏障功能障碍, 内毒素血症和全身性炎症,5)最低和最有效剂量的HD 5在减轻GI- ARS,6)HD 5逆转GI-ARS的暴露后(+24-96 h)有效性的理想时间窗,以及 7)HD 5治疗模式,以增加从致死剂量辐射的存活率。 .

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RADHAKRISHNA RAO其他文献

RADHAKRISHNA RAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RADHAKRISHNA RAO', 18)}}的其他基金

Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage.
定义肠道钙通道在酒精性肝损伤中的作用。
  • 批准号:
    10390126
  • 财政年份:
    2022
  • 资助金额:
    $ 49.16万
  • 项目类别:
Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage.
定义肠道钙通道在酒精性肝损伤中的作用。
  • 批准号:
    10590757
  • 财政年份:
    2022
  • 资助金额:
    $ 49.16万
  • 项目类别:
Mitigation of GI-ARS by Lactobacillus species
乳酸菌物种缓解 GI-ARS
  • 批准号:
    10570082
  • 财政年份:
    2022
  • 资助金额:
    $ 49.16万
  • 项目类别:
Radiation-Induced Paneth Cell Dysfunction
辐射引起的潘氏细胞功能障碍
  • 批准号:
    10686031
  • 财政年份:
    2022
  • 资助金额:
    $ 49.16万
  • 项目类别:
Impact of Stress on Alcoholic Gut Injury
压力对酒精性肠道损伤的影响
  • 批准号:
    9143185
  • 财政年份:
    2016
  • 资助金额:
    $ 49.16万
  • 项目类别:
Impact of Stress on Alcohol-Associated Gut Injury and Systemic Response
压力对酒精相关肠道损伤和全身反应的影响
  • 批准号:
    10485363
  • 财政年份:
    2016
  • 资助金额:
    $ 49.16万
  • 项目类别:
Intestinal Mucosal Protection by Epidermal Growth Factor
表皮生长因子对肠粘膜的保护
  • 批准号:
    8994319
  • 财政年份:
    2015
  • 资助金额:
    $ 49.16万
  • 项目类别:
HYPOGLYCEMIA AND HYPERGLYCEMIA IN DEVELOPING BRAIN
大脑发育中的低血糖和高血糖
  • 批准号:
    8362842
  • 财政年份:
    2011
  • 资助金额:
    $ 49.16万
  • 项目类别:
HYPOGLYCEMIA AND HYPERGLYCEMIA IN DEVELOPING BRAIN
大脑发育中的低血糖和高血糖
  • 批准号:
    8170447
  • 财政年份:
    2010
  • 资助金额:
    $ 49.16万
  • 项目类别:
HYPOGLYCEMIA AND HYPERGLYCEMIA IN DEVELOPING BRAIN
大脑发育中的低血糖和高血糖
  • 批准号:
    7954982
  • 财政年份:
    2009
  • 资助金额:
    $ 49.16万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 49.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 49.16万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 49.16万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 49.16万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 49.16万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 49.16万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 49.16万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 49.16万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 49.16万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 49.16万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了